Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation

被引：0
|
作者：
Kasper, C
Mügge, L
Schilling, K
Scholl, S
Wollina, K
Höffken, K
Sayer, H
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [1] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    Kasper, C
    Sayer, HG
    Mügge, LO
    Schilling, K
    Scholl, S
    Issa, MC
    Höffken, K
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 65 - 69
  • [2] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    C Kasper
    H G Sayer
    L O Mügge
    K Schilling
    S Scholl
    M C Issa
    K Höffken
    [J]. Bone Marrow Transplantation, 2004, 33 : 65 - 69
  • [3] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    [J]. TRANSPLANTATION, 1999, 67 (04) : 499 - 504
  • [4] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    I Haentzschel
    J Freiberg-Richter
    U Platzbecker
    A Kiani
    J Schetelig
    T Illmer
    G Ehninger
    E Schleyer
    M Bornhäuser
    [J]. Bone Marrow Transplantation, 2008, 42 : 113 - 120
  • [5] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Haentzschel, I.
    Freiberg-Richter, J.
    Platzbecker, U.
    Kiani, A.
    Schetelig, J.
    Illmer, T.
    Ehninger, G.
    Schleyer, E.
    Bornhaeuser, M.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 42 (02) : 113 - 120
  • [6] Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis
    Nash, RA
    Furlong, T
    Storb, R
    Anasetti, C
    Appelbaum, FR
    Deeg, HJ
    Doney, K
    Martin, P
    Witherspoon, R
    Sullivan, KM
    [J]. BLOOD, 1997, 90 (10) : 459 - 459
  • [7] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
    Freiberg-Richter, Jens
    Hantzschel, Ingmar
    Jenke, Andreas
    Lorenz, Petra
    Ehninger, Gerhard
    Bornhaeuser, Martin
    [J]. BLOOD, 2006, 108 (11) : 227A - 227A
  • [8] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    [J]. Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [9] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    de Lavallade, H
    Faucher, C
    Bilger, K
    Vey, N
    Stoppa, AM
    Gravis, G
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    [J]. BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
  • [10] Combined tacrolimus (FK-506) and mycophenolate mofetil (MMF) for graft-versus-host disease (GVHD) prophylaxis in children undergoing cord blood transplantation (CBT)
    Soni, S.
    Hente, M.
    Breslin, N.
    Bertolone, S.
    Cheerva, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 66 - 66
12345